brainaid.com

What It Is

BrainAid’s core product, the PEAT Autonomy Kit, is a mobile digital therapy tool for cognitive treatment and rehabilitation. It serves people facing cognitive challenges such as brain injury, stroke, mild cognitive impairment, PTSD, and ADHD. It is not a standard to-do list or calendar app; instead, it is configured by trained therapists to embed personalized routines, reminders, and task prompts into a patient’s cognitive therapy plan. PEAT is not sold directly to consumers and is delivered only through trained service providers.

Core Capabilities

Functionally, PEAT emphasizes “planning—execution—replanning.” Patients receive a personal digital assistant on a phone or tablet to help them remember appointments, arrive on time, complete tasks, take medication, and maintain daily routines. Its standout feature is its AI planning and executive-function software, which can recalculate schedules when real-life disruptions occur, such as interruptions, distractions, oversleeping, or traffic delays. Therapists can also choose to track patient usage to understand memory, behavior, and plan adherence after patients leave the clinic. The website also notes that BrainAid provides therapist training and helps integrate PEAT into existing treatment programs.

Pricing and Delivery

The public pages do not disclose plans, pricing, payment methods, free trials, or enterprise purchasing terms. What can be confirmed is that PEAT uses a service-provider model: healthcare professionals need to contact BrainAid for information. Research institutions interested in collaboration or licensing can also reach out by email.

Pros and Cons

Its strengths lie in its clearly defined vertical use case, years of practical experience with users who have cognitive impairments and their caregivers, and a background that includes NASA-related AI research on autonomous systems, three patents in task planning and execution, and multiple clinical and government-funded research projects. Compared with ordinary reminder tools, it places greater emphasis on dynamic adjustment in real life and clinical supervision. The downsides are its low transparency around commercial information: it does not disclose key enterprise software indicators such as APIs, third-party integrations, cloud or self-hosted deployment, permission management, or data security compliance. It also depends on therapist training and a service network, making it difficult for individuals or ordinary organizations to adopt directly.

Who It’s For and Access in China

PEAT is better suited for rehabilitation hospitals, cognitive therapists, veteran rehabilitation programs, academic research teams, and special education or assisted-living programs, rather than as a general consumer productivity tool. Access from mainland China cannot be determined from the available content and is marked as unknown. If used in a clinical context, additional evaluation would be required regarding local medical device regulations, data compliance, and language localization requirements.